47% revenue increase reported by ICON

Pharmaceutical giant ICON has reported a 47% increase in net revenues to $68.9m (€58.9m) in its Q1 earnings to end August 2003.

The contract clinical research organisation also said that income from operations was $7.6m (€6.5m), up 46% on the $5.2m (€4.4m) reported for the first quarter last year.